| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42c9830b038ed2c5369bf5603b9ded3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e012c20fa6edca66edaa736862732aee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b9a98640c46118d401c803cab097517 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37 |
| filingDate |
2010-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_330f7a5e3b16f26c77610530f329c6ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0820122d7d217bff11ffb3322927409 |
| publicationDate |
2011-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011060372-A2 |
| titleOfInvention |
Factor viii b cell epitope variants having reduced immunogenicity |
| abstract |
Provided herein are methods and compositions for preventing or reducing an initial immune response to factor VIII in patients suffering from hemophilia A, and for reducing the intensity of the immune response in patients having pre-formed inhibitor antibodies against factor VIII. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012035050-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015127129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016501182-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10570189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3466968-A1 |
| priorityDate |
2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |